Report Detail
COVID-19 Impact on Global OTC Gastrointestinal Products Market Insights, Forecast to 2026
- RnM3985280 |
- 03 June, 2020 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
OTC gastrointestinal agents include many different classes of drugs that are used to treat gastrointestinal disorders.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the OTC Gastrointestinal Products market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the OTC Gastrointestinal Products industry.
Based on our recent survey, we have several different scenarios about the OTC Gastrointestinal Products YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of OTC Gastrointestinal Products will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global OTC Gastrointestinal Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global OTC Gastrointestinal Products market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global OTC Gastrointestinal Products market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global OTC Gastrointestinal Products market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global OTC Gastrointestinal Products market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global OTC Gastrointestinal Products market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global OTC Gastrointestinal Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global OTC Gastrointestinal Products market.
The following manufacturers are covered in this report:
GlaxoSmithKline
Merck
Novartis
Bayer
Pfizer
Bristol-Myers Squibb
...
OTC Gastrointestinal Products Breakdown Data by Type
H2 Receptor Antagonists
Proton Pump Inhibitors (PPIs)
OTC Gastrointestinal Products Breakdown Data by Application
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
1 Study Coverage
- 1.1 OTC Gastrointestinal Products Product Introduction
- 1.2 Market Segments
- 1.3 Key OTC Gastrointestinal Products Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global OTC Gastrointestinal Products Market Size Growth Rate by Type
- 1.4.2 H2 Receptor Antagonists
- 1.4.3 Proton Pump Inhibitors (PPIs)
- 1.5 Market by Application
- 1.5.1 Global OTC Gastrointestinal Products Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Drug Stores
- 1.5.4 Retail Stores
- 1.5.5 E-Commerce
- 1.6 Coronavirus Disease 2019 (Covid-19): OTC Gastrointestinal Products Industry Impact
- 1.6.1 How the Covid-19 is Affecting the OTC Gastrointestinal Products Industry
- 1.6.1.1 OTC Gastrointestinal Products Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and OTC Gastrointestinal Products Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for OTC Gastrointestinal Products Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the OTC Gastrointestinal Products Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global OTC Gastrointestinal Products Market Size Estimates and Forecasts
- 2.1.1 Global OTC Gastrointestinal Products Revenue 2015-2026
- 2.1.2 Global OTC Gastrointestinal Products Sales 2015-2026
- 2.2 OTC Gastrointestinal Products Market Size by Region: 2020 Versus 2026
- 2.2.1 Global OTC Gastrointestinal Products Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global OTC Gastrointestinal Products Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global OTC Gastrointestinal Products Competitor Landscape by Players
- 3.1 OTC Gastrointestinal Products Sales by Manufacturers
- 3.1.1 OTC Gastrointestinal Products Sales by Manufacturers (2015-2020)
- 3.1.2 OTC Gastrointestinal Products Sales Market Share by Manufacturers (2015-2020)
- 3.2 OTC Gastrointestinal Products Revenue by Manufacturers
- 3.2.1 OTC Gastrointestinal Products Revenue by Manufacturers (2015-2020)
- 3.2.2 OTC Gastrointestinal Products Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global OTC Gastrointestinal Products Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by OTC Gastrointestinal Products Revenue in 2019
- 3.2.5 Global OTC Gastrointestinal Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 OTC Gastrointestinal Products Price by Manufacturers
- 3.4 OTC Gastrointestinal Products Manufacturing Base Distribution, Product Types
- 3.4.1 OTC Gastrointestinal Products Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers OTC Gastrointestinal Products Product Type
- 3.4.3 Date of International Manufacturers Enter into OTC Gastrointestinal Products Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global OTC Gastrointestinal Products Market Size by Type (2015-2020)
- 4.1.1 Global OTC Gastrointestinal Products Sales by Type (2015-2020)
- 4.1.2 Global OTC Gastrointestinal Products Revenue by Type (2015-2020)
- 4.1.3 OTC Gastrointestinal Products Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global OTC Gastrointestinal Products Market Size Forecast by Type (2021-2026)
- 4.2.1 Global OTC Gastrointestinal Products Sales Forecast by Type (2021-2026)
- 4.2.2 Global OTC Gastrointestinal Products Revenue Forecast by Type (2021-2026)
- 4.2.3 OTC Gastrointestinal Products Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global OTC Gastrointestinal Products Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global OTC Gastrointestinal Products Market Size by Application (2015-2020)
- 5.1.1 Global OTC Gastrointestinal Products Sales by Application (2015-2020)
- 5.1.2 Global OTC Gastrointestinal Products Revenue by Application (2015-2020)
- 5.1.3 OTC Gastrointestinal Products Price by Application (2015-2020)
- 5.2 OTC Gastrointestinal Products Market Size Forecast by Application (2021-2026)
- 5.2.1 Global OTC Gastrointestinal Products Sales Forecast by Application (2021-2026)
- 5.2.2 Global OTC Gastrointestinal Products Revenue Forecast by Application (2021-2026)
- 5.2.3 Global OTC Gastrointestinal Products Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America OTC Gastrointestinal Products by Country
- 6.1.1 North America OTC Gastrointestinal Products Sales by Country
- 6.1.2 North America OTC Gastrointestinal Products Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America OTC Gastrointestinal Products Market Facts & Figures by Type
- 6.3 North America OTC Gastrointestinal Products Market Facts & Figures by Application
7 Europe
- 7.1 Europe OTC Gastrointestinal Products by Country
- 7.1.1 Europe OTC Gastrointestinal Products Sales by Country
- 7.1.2 Europe OTC Gastrointestinal Products Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe OTC Gastrointestinal Products Market Facts & Figures by Type
- 7.3 Europe OTC Gastrointestinal Products Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific OTC Gastrointestinal Products by Region
- 8.1.1 Asia Pacific OTC Gastrointestinal Products Sales by Region
- 8.1.2 Asia Pacific OTC Gastrointestinal Products Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific OTC Gastrointestinal Products Market Facts & Figures by Type
- 8.3 Asia Pacific OTC Gastrointestinal Products Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America OTC Gastrointestinal Products by Country
- 9.1.1 Latin America OTC Gastrointestinal Products Sales by Country
- 9.1.2 Latin America OTC Gastrointestinal Products Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America OTC Gastrointestinal Products Market Facts & Figures by Type
- 9.3 Central & South America OTC Gastrointestinal Products Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa OTC Gastrointestinal Products by Country
- 10.1.1 Middle East and Africa OTC Gastrointestinal Products Sales by Country
- 10.1.2 Middle East and Africa OTC Gastrointestinal Products Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa OTC Gastrointestinal Products Market Facts & Figures by Type
- 10.3 Middle East and Africa OTC Gastrointestinal Products Market Facts & Figures by Application
11 Company Profiles
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Corporation Information
- 11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GlaxoSmithKline OTC Gastrointestinal Products Products Offered
- 11.1.5 GlaxoSmithKline Recent Development
- 11.2 Merck
- 11.2.1 Merck Corporation Information
- 11.2.2 Merck Description, Business Overview and Total Revenue
- 11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Merck OTC Gastrointestinal Products Products Offered
- 11.2.5 Merck Recent Development
- 11.3 Novartis
- 11.3.1 Novartis Corporation Information
- 11.3.2 Novartis Description, Business Overview and Total Revenue
- 11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Novartis OTC Gastrointestinal Products Products Offered
- 11.3.5 Novartis Recent Development
- 11.4 Bayer
- 11.4.1 Bayer Corporation Information
- 11.4.2 Bayer Description, Business Overview and Total Revenue
- 11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Bayer OTC Gastrointestinal Products Products Offered
- 11.4.5 Bayer Recent Development
- 11.5 Pfizer
- 11.5.1 Pfizer Corporation Information
- 11.5.2 Pfizer Description, Business Overview and Total Revenue
- 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Pfizer OTC Gastrointestinal Products Products Offered
- 11.5.5 Pfizer Recent Development
- 11.6 Bristol-Myers Squibb
- 11.6.1 Bristol-Myers Squibb Corporation Information
- 11.6.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
- 11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Bristol-Myers Squibb OTC Gastrointestinal Products Products Offered
- 11.6.5 Bristol-Myers Squibb Recent Development
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Corporation Information
- 11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GlaxoSmithKline OTC Gastrointestinal Products Products Offered
- 11.1.5 GlaxoSmithKline Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 OTC Gastrointestinal Products Market Estimates and Projections by Region
- 12.1.1 Global OTC Gastrointestinal Products Sales Forecast by Regions 2021-2026
- 12.1.2 Global OTC Gastrointestinal Products Revenue Forecast by Regions 2021-2026
- 12.2 North America OTC Gastrointestinal Products Market Size Forecast (2021-2026)
- 12.2.1 North America: OTC Gastrointestinal Products Sales Forecast (2021-2026)
- 12.2.2 North America: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
- 12.2.3 North America: OTC Gastrointestinal Products Market Size Forecast by Country (2021-2026)
- 12.3 Europe OTC Gastrointestinal Products Market Size Forecast (2021-2026)
- 12.3.1 Europe: OTC Gastrointestinal Products Sales Forecast (2021-2026)
- 12.3.2 Europe: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
- 12.3.3 Europe: OTC Gastrointestinal Products Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific OTC Gastrointestinal Products Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: OTC Gastrointestinal Products Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: OTC Gastrointestinal Products Market Size Forecast by Region (2021-2026)
- 12.5 Latin America OTC Gastrointestinal Products Market Size Forecast (2021-2026)
- 12.5.1 Latin America: OTC Gastrointestinal Products Sales Forecast (2021-2026)
- 12.5.2 Latin America: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
- 12.5.3 Latin America: OTC Gastrointestinal Products Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa OTC Gastrointestinal Products Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: OTC Gastrointestinal Products Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: OTC Gastrointestinal Products Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key OTC Gastrointestinal Products Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 OTC Gastrointestinal Products Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global OTC Gastrointestinal Products. Industry analysis & Market Report on COVID-19 Impact on Global OTC Gastrointestinal Products is a syndicated market report, published as COVID-19 Impact on Global OTC Gastrointestinal Products Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global OTC Gastrointestinal Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
